Original language | English |
---|---|
Pages (from-to) | 80046-80058 |
Journal | Oncotarget |
Volume | 7 |
Issue number | 48 |
DOIs | |
Publication status | Published - 29 Nov 2016 |
First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors
C. W. Menke, Carlos Gomez-Roca, Carla van Herpen, Andrew L. Coveler, Devalingam Mahalingam, Henk M. W. Verheul, Winette T. A. van der Graaf, Randolph Christen, Dominik Ruettinger, Stefan Weigand, Michael A. Cannarile, Florian Heil, Michael Brewster, Antje-Christine Walz, Tapan K. Nayak, Ernesto Guarin, Valerie Meresse, Christophe Le Tourneau
Research output: Contribution to journal › Article › Academic › peer-review